MDxHealth SA expected to post a loss of 11 cents a share - Earnings Preview

MDxHealth SA

12/08/2025 15:02

MDxHealth SA MDXH.OQ MDXH.O is expected to  show a rise in quarterly revenue when it reports  results on August 14 for the period ending September 30 2025

The Herstal Liege-based  company is expected to report a 20.4% increase in revenue to $28.08 million from $23.32 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.

‚ÄčLSEG's mean analyst estimate for MDxHealth SA is for a loss of 11 cents per share.

The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts had fallen by about 21.6% in the last three months. ‚Äč

Wall Street's median 12-month price target for MDxHealth SA is $6.00, about 52% above its last closing price of $2.88

Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äč

QUARTER ENDING
STARMINESMARTESTIMATE¬ģ
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Jun. 30 2025
-0.14
-0.12
-0.15
Missed
-21
Mar. 31 2025
-0.13
-0.13
-0.19
Missed
-46.2
Dec. 31 2024
-0.18
-0.19
-0.14
Beat
27.1‚Äč
Sep. 30 2024
-0.28
-0.27
-0.40
Missed
-48.1
‚Äč‚ÄčJun. 30 2024
-0.27
-0.26
-0.42
Missed
-58.5
Mar. 31 2024
-0.31
-0.30
-0.31
Missed
-3.3‚Äč
Dec. 31 2023
-0.22
-0.11
-0.39
Missed
-254.5
Sep. 30 2023
-0.21
-0.19
-0.40
Missed
-108.3

This summary was machine generated August 12 at 14:02 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)